Biocon rises as its arm inks settlement, license pact with Amgen

01 Oct 2025 Evaluate

Biocon is currently trading at Rs. 346.35, up by 5.50 points or 1.61% from its previous closing of Rs. 340.85 on the BSE.

The scrip opened at Rs. 340.20 and has touched a high and low of Rs. 348.15 and Rs. 340.20 respectively. So far 30779 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 405.90 on 18-Jul-2025 and a 52 week low of Rs. 290.80 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 367.95 and Rs. 337.20 respectively. The current market cap of the company is Rs. 46305.74 crore.

The promoters holding in the company stood at 54.45%, while Institutions and Non-Institutions held 28.86% and 16.68% respectively.

Biocon’s subsidiary -- Biocon Biologics has executed the settlement and license agreement with Amgen Inc. that clears the path for the commercialization of Bosaya (denosumab-kyqq) and Aukelso (denosumab-kyqq) in the United States (U.S.). Biocon Biologics and Amgen have executed the settlement agreement to resolve the pending patent litigation at the United States District Court for the District of New Jersey. The agreement enables Biocon Biologics to launch BOSAYA and AUKELSO in the U.S. from October 1, 2025. Biocon Biologics is a fully integrated global biosimilars company.

Bosaya 60 mg/mL injection in a single-dose prefilled syringe (PFS) and Aukelso 120 mg/1.7 mL, 70 mg/mL injection for subcutaneous use in a single-dose vial, are biosimilars to Amgen’s Prolia and Xgeva, respectively. These products are used in the treatment of osteoporosis and cancer-related bone conditions.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×